Market Cap $ M 13.81
Enterprise Value $ M 13.81
P/E(ttm) --
PE Ratio without NRI --
Forward PE Ratio --
Price/Book --
Price/Sales --
Price/Free Cash Flow --
Price/Owner Earnings --
Payout Ratio % --
Revenue (TTM) $ M 135.00
EPS (TTM) $ -5.69
Beneish M-Score 0
10-y EBITDA Growth Rate % --
5-y EBITDA Growth Rate % --
y-y EBITDA Growth Rate % --
EV-to-EBIT --
EV-to-EBITDA --
PEG --
Shares Outstanding M 19.62
Net Margin (%) --
Operating Margin % --
Pre-tax Margin (%) --
Quick Ratio --
Current Ratio --
ROA % (ttm) --
ROE % (ttm) --
ROIC % (ttm) --
Dividend Yield % --
Altman Z-Score --
Piotroski F-Score --
Positive ROA N
Positive CFROA N
Higher ROA y-y N
Cash flow > Earnings N
Lower Leverage y-y N
Higher Current Ratio y-y N
Less Shares Outstanding y-y N
Gross Margin Increase y-y N
Higher Asset Turnover y-y N

NVLNF Number of Guru Trades

To

NVLNF Volume of Guru Trades

To

Gurus Latest Trades with OTCPK:NVLNF

No Available Data

OTCPK:NVLNF is held by these investors

No Available Data

Novelion Therapeutics Inc Insider Transactions

No Available Data

News about OTCPK:NVLNF

Total 0
  • 1